Miguel Brito Lança

Dr. Miguel Brito Lança

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2023 in Genes
Verified
Journal Article
Open access
PDF file
PBPedro Baltazar
Pedro Baltazar
AJAntonio Ferreira Melo Junior
Antonio Ferreira Melo Junior
NFNuno Moreira Fonseca
Nuno Moreira Fonseca
MLMiguel Brito Lança
Miguel Brito Lança
AFAna Faria
Ana Faria
Sofia pereiraSofia pereira
Sofia pereira
Oxalate is a metabolic end-product whose systemic concentrations are highly variable among individuals. Genetic (primary hyperoxaluria) and non-genetic (e.g., diet, microbiota, renal and metabolic disease) reasons underlie elevated plasma concentrations and tissue accumulation of oxalate, which is toxic to the body. A classic example is the triad of primary hyperoxaluria, nephrolithiasis, and kidney injury. Lessons learned from this example suggest further investigation of other putative factors associated with oxalate dysmetabolism, namely the identification of precursors (glyoxylate, aromatic amino acids, glyoxal and vitamin C), the regulation of the endogenous pathways that produce oxalate, or the microbiota’s contribution to oxalate systemic availability. The association between secondary nephrolithiasis and cardiovascular and metabolic diseases (hypertension, type 2 diabetes, and obesity) inspired the authors to perform this comprehensive review about oxalate dysmetabolism and its relation to cardiometabolic toxicity. This perspective may offer something substantial that helps advance understanding of effective management and draws attention to the novel class of treatments available in clinical practice.

31 March 2026 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
DSDiana Santos
Diana Santos
MLMiguel Brito Lança
Miguel Brito Lança
DNDavid Navarro
David Navarro
PBPedro Baltazar
Pedro Baltazar
CJCristina Jorge
Cristina Jorge
NFNuno Moreira Fonseca
Nuno Moreira Fonseca
Primary hyperoxaluria type 3 is a rare autosomal recessive disorder caused by HOGA1 mutations, leading to recurrent calcium oxalate nephrolithiasis. Diagno

22 November 2023 in European Urology Open Science
Verified
Journal Article
Open access
JGJ.P. Ferreira Guerra
J.P. Ferreira Guerra
JPJ. Pina
J. Pina
VAV. Andrade
V. Andrade
MMM. Medeiros
M. Medeiros
MGM. Gil
M. Gil
LPL.S. Campos Pinheiro
L.S. Campos Pinheiro